chr3-64686890-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000498707.5(ADAMTS9):āc.194C>Gā(p.Thr65Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,614,196 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000498707.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS9 | NM_182920.2 | c.194C>G | p.Thr65Arg | missense_variant | 2/40 | ENST00000498707.5 | NP_891550.1 | |
ADAMTS9-AS2 | NR_038264.1 | n.469+1552G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS9 | ENST00000498707.5 | c.194C>G | p.Thr65Arg | missense_variant | 2/40 | 1 | NM_182920.2 | ENSP00000418735 | P1 | |
ADAMTS9-AS2 | ENST00000650103.1 | n.404+1552G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000254 AC: 64AN: 251484Hom.: 1 AF XY: 0.000346 AC XY: 47AN XY: 135914
GnomAD4 exome AF: 0.000222 AC: 324AN: 1461888Hom.: 3 Cov.: 32 AF XY: 0.000261 AC XY: 190AN XY: 727244
GnomAD4 genome AF: 0.000223 AC: 34AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74472
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | ADAMTS9: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 05, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects ADAMTS9 function (PMID: 30609407). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 1344640). This missense change has been observed in individual(s) with ADAMTS9-related conditions (PMID: 30609407). This variant is present in population databases (rs192420947, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 65 of the ADAMTS9 protein (p.Thr65Arg). - |
Nephronophthisis Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Jan 03, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at